Skip to main content
No. of Recommendations: 14
I still love ARE and AREEP, and have been buying a lot more of both. I exchanged emails with CEO Joel Marcus recently, and learned that, in his entire history in this business, market conditions have never been this good. A key factor is the substantial jump in new FDA drug approvals and the availability of capital to many younger players. Why the stock is still trading below NAV is a riddle I am not able to answer. But I am taking advantage (at least I think I am), especially at prices below $96.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.